Global B2B Pharmaceutical Marketplace Β· Sourcing Β· Named-Patient Access
πŸ’¬ WhatsApp Β· Sign in Β· Register

Explore Top Pharmaceutical Products, APIs, Formulations & Intermediates from Verified Suppliers

Dabrafenib

Strength:
50 mg ,75 mg

Form: Capsules

Reference Brands: Tafinlar (USA/EU)

View More Get Enquiry

Capmatinib

Strength:
150 mg, 200 mg

Form: Tablets

Reference Brands: Tabrecta (USA/EU)

View More Get Enquiry

Nafarelin Acetate

Strength:
2 mg/mL

Form: Nasal Spray

Reference Brands: Synarel (USA)

View More Get Enquiry

Naldemedine

Strength:
0.2 mg

Form: Tablets

Reference Brands: Symproic (USA/EU)

View More Get Enquiry

Histrelin Acetate

Strength:
50 mg

Form: Subcutaneous implant

Reference Brands: Vantas (USA), Supprelin LA (USA)

View More Get Enquiry

Solriamfetol

Strength:
75 mg, 150 mg

Form: Tablets

Reference Brands: Sunosi (USA/EU)

View More Get Enquiry

Lenacapavir

Strength:
300 mg, 463.5 mg/1.5 mL

Form: Tablet / Injection

Reference Brands: Yeztugo (USA), Sunlenca (USA)

View More Get Enquiry

Sulindac

Strength:
150 mg, 200 mg

Form: Tablets

Reference Brands: Clinoril (USA/EU)

View More Get Enquiry

Sufentanil Citrate

Strength:
50 mcg/mL, 100 mcg/mL, 15 mcg

Form: Tablet / Injection

Reference Brands: Sufenta (USA/EU), Dsuvia (USA/EU)

View More Get Enquiry

Regorafenib

Strength:
40 mg, 80 mg, 120 mg, 160 mg

Form: Tablets

Reference Brands: Stivarga (USA/EU)

View More Get Enquiry

Olodaterol

Strength:
2.5 mcg

Form: Inhalation solution

Reference Brands: Striverdi Respimat (USA)

View More Get Enquiry

Deucravacitinib

Strength:
6 mg

Form: Tablet

Reference Brands: Sotyktu (USA/EU)

View More Get Enquiry

Secnidazole

Strength:
2 g

Form: Oral granules/ tablets

Reference Brands: Solosec (USA)

View More Get Enquiry

Solifenacin Succinate

Strength:
5 mg ,10 mg

Form: Tablets

Reference Brands: Vesicare (USA/EU)

View More Get Enquiry

Palovarotene

Strength:
5 mg, 10 mg

Form: Capsules

Reference Brands: Sohonos (USA/EU)

View More Get Enquiry

Subscribe to Our Newsletter

Stay updated on pharma trends and marketplace opportunities.

Please enter the correct answer.
This website uses cookies to ensure you get the best experience. By using our site, you agree to our Privacy Policy.